CD49b, a Major Marker of Regulatory T-Cells Type 1, Predicts the Response to Antiviral Therapy of Recurrent Hepatitis C after Liver Transplantation

The TRANSPEG study was a prospective study to assess the efficacy of antiviral therapy in patients with a recurrent hepatitis C virus (HCV) after liver transplantation. The influence of regulatory T-cells (Tregs) on the response to antiviral therapy was analyzed. Patients were considered as a functi...

Descripción completa

Detalles Bibliográficos
Autores principales: Fabien, Stenard, Olivier, Morales, Khaldoun, Ghazal, Vivian, Viallon, Lynda, Aoudjehane, Laurissa, Ouaguia, Gautier, Goormachtigh, Yvon, Calmus, Nadira, Delhem, Filomena, Conti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3915765/
https://www.ncbi.nlm.nih.gov/pubmed/24575405
http://dx.doi.org/10.1155/2014/290878

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3915765/
https://www.ncbi.nlm.nih.gov/pubmed/24575405
http://dx.doi.org/10.1155/2014/290878

Ejemplares similares